Acorda Therapeutics, Inc. (ACOR) Financials
ACOR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 366.3 million | 307.4 million |
2023-06-30 | 364.7 million | 296.8 million |
2023-03-31 | 374.9 million | 297.9 million |
2022-12-31 | 395.6 million | 302.0 million |
ACOR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 7.4 million | 141000 |
2023-06-30 | -11.6 million | 128000 |
2023-03-31 | -7.0 million | 71000 |
2022-12-31 | 9.1 million | 173000 |
ACOR Net Income
No data available :(
ACOR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 32.5 million | - | 5.0 million |
2023-06-30 | 25.3 million | - | 5.3 million |
2023-03-31 | 30.3 million | - | 5.6 million |
2022-12-31 | 37.5 million | - | 5.9 million |
ACOR Shares Outstanding
ACOR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 220000 | 1.2 million | 23.2 million | - |
2023-06-30 | - | 1.6 million | 21.8 million | - |
2023-03-31 | - | 1.4 million | 22.5 million | - |
2022-12-31 | 14000 | 1.2 million | 26.3 million | - |
ACOR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 27.7 million | 3.4 million |
2023-06-30 | 29.7 million | 3.1 million |
2023-03-31 | 22.3 million | 3.2 million |
2022-12-31 | 31.5 million | 4.6 million |
ACOR
Price: $0.66
52 week price:
Payout Ratio Range:
Earnings Per Share: -203.57 USD
P/E Ratio: 5.98
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 250200
Ebitda: -218.1 millionMarket Capitalization: 821028